This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Blumenfeld, Z. Articles by Scharf, Y. Search for Related Content PubMed PubMed Citation Articles by Blumenfeld, Z. Articles by Scharf, Y. Social Bookmarking                         What's this?

Systemic Lupus Erythematosus: Predisposition for Uterine Cervical Dysplasia

Department of Obstetrics and Gynecology; Rambam Medical Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, 31096, Israel

M. Lorber

B. Shine Department of Rheumatology, Rambam Medical Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, 31096, Israel

N. Yoffe

Department of Obstetrics and Gynecology; Rambam Medical Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, 31096, Israel

Y. Scharf

B. Shine Department of Rheumatology, Rambam Medical Center, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, 31096, Israel

A previous retrospective study has found an increased risk of uterine cervical atypia in women with systemic lupus erythematosus (SLE) who have been treated with cytotoxic drugs. Our objective was to prospectively reveal any increased incidence of cervical atypia in SLE patients and to evaluate the relationship to previous chemotherapy. A total of 39 SLE women were prospectively referred for cytologic PAP smears of the uterine cervix. A significantly higher incidence of cervical atypia was found in SLE women (35.9%) compared with non-SLE control groups (5%; P < 0.01). No significant difference was found between the incidence of atypia in patients previously treated by cytotoxic medications such as cyclophosphamide pulses or methotrexate (4 of 9) compared with SLE women not receiving cytotoxic drugs (10 of 30). Colposcopically directed biopsies revealed three cases of cervical intraepithelial neoplasia (CIN) I-III (23%) among the cases with atypia. We conclude that women with SLE should have regular cytologic cervical smears because of a significantly increased incidence of atypia, regardless of previous cytotoxic therapy.

Key Words: Systemic lupus erythematosus • Cervical atypia • Dysplasia • Cervical cancer • Cytotoxic treatment

Lupus, Vol. 3, No. 1, 59-61 (1994)
DOI: 10.1177/096120339400300112


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L.-S. TAM, P. K.S. CHAN, S. C. HO, M. M.Y. YU, S.-F. YIM, T.-H. CHEUNG, M. C.S. WONG, and E. K. LI Natural History of Cervical Papilloma Virus Infection in Systemic Lupus Erythematosus -- A Prospective Cohort Study J Rheumatol, February 1, 2010; 37(2): 330 - 340. [Abstract] [Full Text] [PDF]

				M Gayed, S Bernatsky, R Ramsey-Goldman, A. Clarke, and C Gordon Lupus and cancer Lupus, May 1, 2009; 18(6): 479 - 485. [Abstract] [PDF]

				M.V. Febronio, R.M.R. Pereira, E. Bonfa, A.D. Takiuti, E.A.G. Pereyra, and C.A.A. Silva Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus Lupus, June 1, 2007; 16(6): 430 - 435. [Abstract] [PDF]

				S. Bernatsky, R. Ramsey-Goldman, C. Gordon, L. Joseph, J.-F. Boivin, R. Rajan, A. Allen, A. D. Moore, M.-H. Leung, and A. Clarke Factors associated with abnormal Pap results in systemic lupus erythematosus Rheumatology, November 1, 2004; 43(11): 1386 - 1389. [Abstract] [Full Text] [PDF]

				M Petri Cyclophosphamide: new approaches for systemic lupus erythematosus Lupus, May 1, 2004; 13(5): 366 - 371. [Abstract] [PDF]

				C. Gordon Long-term complications of systemic lupus erythematosus Rheumatology, October 1, 2002; 41(10): 1095 - 1100. [Full Text] [PDF]

				D. Bouros, K. Hatzakis, H. Labrakis, and K. Zeibecoglou Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes* Chest, April 1, 2002; 121(4): 1278 - 1289. [Abstract] [Full Text] [PDF]

				O Nived, A Bengtsson, A Jonsen, G Sturfelt, and H Olsson Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden Lupus, July 1, 2001; 10(7): 500 - 504. [Abstract] [PDF]

				R Ramsey-Goldman and A E Clarke Double trouble: are lupus and malignancy associated? Lupus, June 1, 2001; 10(6): 388 - 391. [PDF]

				J Cibere, J Sibley, and M Haga Systemic lupus erythematosus and the risk of malignancy Lupus, June 1, 2001; 10(6): 394 - 400. [Abstract] [PDF]

				H Bateman, Y Yazici, L Leff, M Peterson, and S A Paget Increased cervical dysplasia in intravenous cyclophosphamidetreated patients with SLE: a preliminary study Lupus, September 1, 2000; 9(7): 542 - 544. [Abstract] [PDF]

				D. L. S. Eustace Systemic Lupus Erythematosus and Uterine Cervical Neoplasia Lupus, February 1, 1994; 3(1): 3 - 4. [PDF]